“…[ [10] , [11] , [12] , [13] , 17 , [23] , [24] , [25] , [26] ] The prevalence of depressive symptoms ranged between 32.1%–94.0%. [ [10] , [11] , [12] , [13] , 17 , [23] , [24] , [25] , [26] ] Most of these studies used the Generalized Anxiety Disorder 7 (GAD-7) [ 11 , 12 , 15 , 16 , 23 , 24 , [26] , [27] , [28] ] and Patient Health Questionnaire 9 (PHQ-9) [ 12 , 15 , 23 , 24 , 26 , 28 ] to determine anxiety and depression. Other data collection tools included the 10-item Cohen Perceived Stress Scale [ 10 , 26 , 27 , 29 ], 14-item Shirom-Melamed Burnout measure [ 10 ], 7-item Insomnia Severity Index [ 12 , 26 , 28 , 30 ], 22-item Impact of Event Scale-Revised [ 12 , 28 ], 16-item Stanford Professional Fulfilment Index [ 12 , 28 ], Hospital Anxiety Depression Score [ 13 ], Coronavirus Anxiety Scale [ 17 ] and Primary Care PTSD Screen.…”